Literature DB >> 5567771

Creatine phosphokinase in facioscapulohumeral muscular dystrophy.

B P Hughes.   

Abstract

Study of the serum creatine kinase levels in young patients with facioscapulohumeral muscular dystrophy suggests that enzyme assay may be valuable as a screening procedure for assessing the status of relatives of an affected individual who have no previous clinical history, and that consequently it may be of use in genetic counselling.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5567771      PMCID： PMC1800383          DOI： 10.1136/bmj.3.5772.464

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  3 in total

1.  Serum enzyme activity in muscular dystrophy.

Authors:  W H THOMSON; P LEYBURN; J N WALTON
Journal:  Br Med J       Date:  1960-10-29

2.  Serum creatine phosphokinase and haemolysis.

Authors:  B P Hughes
Journal:  Clin Chim Acta       Date:  1968-08       Impact factor: 3.786

3.  Neurogenic atrophy simulating facioscapulohumeral dystrophy. A dominant form.

Authors:  G M Fenichel; E S Emery; P Hunt
Journal:  Arch Neurol       Date:  1967-09
  3 in total
  2 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  Genetic counselling in facioscapulohumeral muscular dystrophy.

Authors:  P W Lunt; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.